Quris AI

We were honored to participate in Drug R&D 2025, where our VP of Biology, Dr. Amir Bein, had the opportunity to present and engage with leading experts in the field. The insights shared have further fueled our commitment to revolutionizing drug development and fostering a collaborative community of industry leaders, researchers, young innovators, and government officials. We hope to continue collaborating and driving meaningful progress together! ???? Let’s shape the future of drug discovery! #DrugRND #QurisAI #AIinPharma #BiotechInnovation #FutureOfMedicine

?? We’re LIVE at #SOT2025! ?? Come visit us at Booth #1265 at the Society of Toxicology (SOT) Annual Meeting & ToxExpo in Orlando! ? Fuel up with coffee (and hit your caffeine Cmax ??) ?? Learn how our AI-powered Bio-AI platform predicts DILI with unmatched accuracy ?? Meet our team and explore how we can collaborate Swing by to see how we’re revolutionizing drug safety prediction. See you at Booth #1265! #SOT #DrugSafety #AI #BioAI #DILI #Toxicology #SOT2025

Take a Look Under the Hood of the Most Accurate DILI Prediction Platform! ?? Want to learn more? Stop by Booth #1265 at SOT next week for a live demonstration of our platform. Let’s connect—see you there! #SOT2025 #DrugSafety #AI #Toxicology #DILI #Pharma

?? Under the Hood of the Most Accurate DILI Prediction Platform ?? How do we build a machine-learning platform that predicts drug-induced liver injury (DILI) with unparalleled accuracy? This two-minute video takes you behind the scenes of our approach, combining cutting-edge AI with a 3D liver model to revolutionize drug safety prediction. ?? Watch the video to see how we do it. ?? For a deeper dive, reach out to Gil Azulay ?? Or better yet—meet us in person at booth #1265 at SOT next week!

Quris-AI is heading to SOT 2025! We’re excited to exhibit at the 64th Annual SOT Meeting & ToxExpo in Orlando, Florida, March 16-20, 2025! Visit us at Booth #1265 to discover how we are revolutionizing drug safety prediction with our AI-powered Bio-AI platform. Let's connect and explore the future of predictive toxicology—reducing drug failure rates and enhancing patient safety through cutting-edge technology. #SOT2025 #ToxExpo #DrugSafety #AIinPharma #Biotech #PharmaInnovation #QurisAI

Revolutionizing Drug Development with Bio-AI ?? At Abu Dhabi Global Healthcare Week, our Founder and CEO, Isaac Bentwich, explored how AI is reshaping drug development—eliminating reliance on animal testing, predicting patient safety with greater accuracy, and accelerating clinical trials. As the industry moves toward a smarter, more ethical future, Bio-AI is leading the way in ensuring safer, faster, and more cost-effective drug discovery. #BioAI #DrugSafety #FutureofMedicine #ADGHW #AIinHealthcare #QurisAI

Quris AI is pioneering AI-driven drug development. Traditional clinical trials are expensive and can be inaccurate, but Quris' Bio-AI Clinical Prediction Platform is changing that. By integrating AI with patient-on-chip technology, Quris is creating safer, more efficient drug testing processes—revolutionizing the pharma industry. See how this innovation is reshaping medicine: https://bit.ly/3MaBoCa #PharmaInnovation #ArtificialIntelligence #InsideTheBlueprint #DrugDevelopment #BioTech

Predicting Patient Safety with Precision ?? Traditional drug testing models are riddled with uncertainty, leading to costly failures and patient risks. By integrating AI-driven insights with organ-on-a-chip technology, drug safety can now be predicted with unmatched accuracy—before clinical trials even begin. With Merck KGaA among those adopting this cutting-edge approach, the industry is moving toward a future where safer, more effective drugs reach patients faster. The shift is happening now. Read more: https://lnkd.in/dtAaByc8 #BioAI #DrugSafety #NoMoreGuesswork #FutureofMedicine #ClinicalTrials

Big news! Merck KGaA, Darmstadt, Germany, has adopted Quris AI's Bio-AI platform for preclinical small molecule safety testing after a successful collaborative two-year validation study. Together, we are accelerating safer drug development and reducing reliance on animal testing. #AI #PharmaInnovation #DrugSafety #QurisAI

Quris AI's latest article, created in collaboration with MBZUAI (Mohamed bin Zayed University of Artificial Intelligence), has been published at NeurIPS 2024 and is featured at the NIPS conference in Canada! This groundbreaking work showcases how AI and organ-on-a-chip technologies are advancing predictive drug safety and transforming healthcare. We’re proud to be part of this innovation and look forward to more collaborations in the future! ?? Check out the article here: https://lnkd.in/dXZpsqdz #NeurIPS2024 #AI #DrugSafety #Innovation #Collaboration